# How to Assess Risk of Bias in Animal Studies
## Quick Answer
- Use SYRCLE's Risk of Bias tool for animal studies because it adapts Cochrane's human clinical trial domains to the specific realities of preclinical animal research.
- Apply the tool during systematic review planning, not after data extraction, and record each judgment with a clear rationale in a review protocol.
- The tool assesses methodological quality, not reporting quality, so a study can receive unclear risk ratings when authors omit key experimental details.
## At a Glance
| Domain | What It Assesses | Common Animal Study Example | Typical Risk Rating |
|--------|------------------|----------------------------|---------------------|
| Selection bias | Whether groups were comparable at baseline | Random housing assignment vs. picking animals from the most accessible cage | Low if randomization is described, High if animals are chosen by convenience |
| Performance bias | Whether animals and staff knew group assignments | Blinded caregivers vs. same technician who knows which animals received treatment | Low with blinding, High when blinding is absent or impossible |
| Detection bias | Whether outcome assessors were blinded | Blinded pathologist scoring lesions vs. investigator who also administered treatment | Low with blinded assessment, High when the same person measures and treats |
| Attrition bias | Whether all animals were accounted for in analysis | Reporting all animals that died vs. excluding animals that did not respond to treatment | Low with complete reporting, High when exclusions are unexplained |
| Reporting bias | Whether all measured outcomes were reported | Publishing only significant findings vs. reporting all pre-specified endpoints | Low with a pre-registered protocol, High when outcomes are selectively reported |
## Why Standard Risk of Bias Tools Fall Short for Animal Studies
Systematic reviewers who work exclusively with human clinical trials often reach for the Cochrane Risk of Bias tool when they first encounter animal studies. That instinct creates a mismatch. The Cochrane tool was designed for randomized controlled trials in humans, where the unit of randomization is typically a person, the intervention is often a drug or procedure, and the outcome is measured in the same individual throughout the study. Animal studies introduce a different set of structural features that the Cochrane tool does not directly address.
Animal experiments commonly use littermates from the same dam, which creates clustering effects that human trials rarely face. Animals are often housed in groups, so the cage instead of the individual animal may be the true unit of intervention. The same animal may be used for multiple measurements over time, and the investigator often controls the environment completely, from temperature to light cycles to feeding schedules. These features matter because they create specific opportunities for bias that a human-focused tool would miss.
The SYRCLE Risk of Bias tool was developed specifically to close this gap. It takes the ten domains from the Cochrane Collaboration's tool and adapts them to the vocabulary and practical realities of animal experimentation. The tool retains the core structure of sequence generation, baseline characteristics, allocation concealment, random housing, blinding, incomplete outcome data, selective outcome reporting, and other sources of bias. What changes is the operational definition of each domain in the context of animal research.
A researcher who applies the Cochrane tool to an animal study will find that several domains do not translate cleanly. Allocation concealment in a human trial means hiding the treatment assignment from the person who enrolls participants. In an animal study, the equivalent concern is whether the person who assigns animals to experimental groups knows which group will receive which treatment. Random housing, a domain that does not exist in the Cochrane tool, addresses whether cages were distributed randomly across the room to prevent location effects from confounding the results.
The practical consequence of using the wrong tool is that reviewers may mark domains as low risk when the animal-specific features of the study create real bias. A study can have perfect sequence generation and still be biased if all treated animals were housed on the top shelf of the rack where light exposure differed. The SYRCLE tool forces the reviewer to ask that question explicitly.
## The Ten Domains of the SYRCLE Tool
### Sequence Generation
The first domain asks whether the order in which animals were assigned to groups was truly random. A proper random sequence means that each animal had an equal and independent chance of being assigned to any experimental group. Acceptable methods include computer-generated random number tables, random number generators, or drawing lots from a container. Unacceptable methods include assignment by date of birth, cage number, or the order in which animals arrived from the breeding facility.
In practice, many animal studies describe animals as randomly assigned without specifying the method. That description is insufficient for a low-risk judgment. The reviewer needs to know whether the randomization was generated by a process that could not be predicted or manipulated. When the method is not described, the domain receives an unclear risk rating.
### Baseline Characteristics
This domain examines whether the experimental groups were comparable at the start of the study. Important baseline variables in animal studies include age, weight, sex, and genetic background. Even with proper randomization, small sample sizes can produce groups that differ by chance. The reviewer should look for a table or description of baseline characteristics for each group.
A study that reports baseline data and shows no meaningful differences between groups earns a low-risk rating. A study that does not report baseline characteristics, or that reports them only for some groups, earns an unclear rating. A study that shows clear baseline differences, such as one group being significantly heavier or older than another, earns a high-risk rating because those differences can confound the treatment effect.
### Allocation Concealment
Allocation concealment asks whether the person who assigned animals to groups knew the allocation sequence in advance. If the investigator knows which group the next animal will enter, that knowledge can influence which animal is assigned to which group, even if the sequence itself was randomly generated.
In animal studies, allocation concealment is often achieved by having a person who is not involved in the experiment generate the random sequence and prepare the group assignments. The person who actually handles the animals then follows the assignments without knowing the sequence in advance. When the method of concealment is not described, the domain receives an unclear rating.
### Random Housing
Random housing is a domain that is unique to animal research. It asks whether the animals were housed randomly across the cages or pens in the animal facility. This matters because environmental factors such as light exposure, temperature gradients, noise, and human traffic can vary across a room. If all treated animals are housed on one side of the room and all control animals on the other, any environmental difference becomes a confounder.
A study that describes random cage placement, or that uses a rotation system to equalize environmental exposure, earns a low-risk rating. A study that does not describe housing arrangements earns an unclear rating. A study that explicitly states that all animals in one group were housed together in a separate room or area earns a high-risk rating.
### Blinding of Caregivers and Investigators
Performance bias arises when the people who care for the animals or administer the interventions know which animals received which treatment. This knowledge can influence behavior in subtle ways, such as handling animals differently, administering the intervention with more or less care, or making subjective decisions about animal welfare during the study.
Blinding in animal studies is often difficult but not impossible. Investigators can use coded treatments so that the person administering the intervention does not know whether they are giving the active compound or the vehicle control. Caregivers can be kept unaware of group assignments when the experimental design permits. When blinding is not described, the domain receives an unclear rating.
### Random Outcome Assessment
Random outcome assessment asks whether the order in which animals were assessed for outcomes was randomized. This matters because outcomes that involve subjective judgment, such as scoring the severity of a lesion or rating the degree of behavioral change, can be influenced by fatigue, expectation, or the order in which animals are evaluated.
A study that randomizes the order of outcome assessment, or that uses automated and objective outcome measurements, earns a low-risk rating. A study that does not describe the assessment order earns an unclear rating.
### Blinding of Outcome Assessors
Detection bias arises when the person who measures or assesses the outcome knows which animals received which treatment. This is a distinct concern from blinding of caregivers. An investigator can be blinded during the intervention phase but unblinded during the outcome assessment phase.
Blinding of outcome assessors is often more feasible than blinding of caregivers. A pathologist who scores tissue sections can be given coded slides without knowing which group each sample came from. A technician who measures behavioral outcomes can be kept unaware of group assignments. When the outcome assessment is subjective and the assessor was not blinded, the domain earns a high-risk rating.
### Incomplete Outcome Data
Attrition bias arises when animals are excluded from the analysis or when data are missing for some animals. Common causes of incomplete outcome data in animal studies include death during the experiment, technical failure of a measurement, or the investigator's decision to remove an animal that appears to be an outlier.
The reviewer must ask whether the number of animals reported in the results matches the number that started the study. When animals are excluded, the reviewer must ask whether the exclusions were explained and whether the reasons for exclusion could be related to the treatment. A study that reports all animals and explains any exclusions earns a low-risk rating. A study that excludes animals without explanation, or that excludes animals because they did not respond to treatment, earns a high-risk rating.
### Selective Outcome Reporting
Selective outcome reporting occurs when the authors report only some of the outcomes they measured, typically the ones that showed statistically significant results. This bias is difficult to detect unless the study protocol was pre-registered or the authors report all measured outcomes.
A study that references a pre-registered protocol and reports all pre-specified outcomes earns a low-risk rating. A study that does not reference a protocol and reports only selected outcomes earns an unclear rating. A study that clearly omits outcomes that were measured but not reported earns a high-risk rating.
### Other Sources of Bias
The final domain captures any other features of the study that could introduce bias. Examples include conflicts of interest, the use of an inappropriate animal model for the research question, contamination between treatment groups, or the use of a vehicle control that differs from the treatment in ways other than the active ingredient.
The reviewer should describe any additional concerns in this domain and rate the risk accordingly. When no other concerns are identified, the domain earns a low-risk rating.
## How the Tool Differs From the Cochrane Approach
The SYRCLE tool shares the same conceptual foundation as the Cochrane tool, but the operational details differ in ways that matter for animal research. The most significant difference is the addition of random housing as a distinct domain. This domain exists because the physical environment of an animal facility can introduce bias that has no direct analog in human clinical trials.
Another difference is the emphasis on the unit of analysis. In human trials, the individual person is almost always the unit of randomization and analysis. In animal studies, the unit of randomization may be the cage, the litter, or the individual animal. The SYRCLE tool requires the reviewer to consider whether the analysis accounted for the unit of randomization. A study that randomizes by cage but analyzes by individual animal without accounting for clustering may produce artificially narrow confidence intervals and inflated significance levels.
The tool also places greater emphasis on the distinction between caregivers and outcome assessors. In animal studies, these roles are often performed by the same person, which increases the risk of bias. The tool requires the reviewer to assess blinding separately for each role.
## Practical Steps for Applying the Tool
### Step 1: Assemble the Review Team
Risk of bias assessment should be conducted by at least two reviewers working independently. Each reviewer applies the tool to each included study and records their judgments. The reviewers then compare their assessments and resolve disagreements through discussion or by consulting a third reviewer. This process reduces the risk that one reviewer's subjective judgment determines the outcome.
### Step 2: Read Each Study in Full
The risk of bias assessment requires the full text of each study, beyond the abstract. Many details that are relevant to the assessment, such as the method of randomization, the housing arrangement, and the blinding procedures, are reported only in the methods section of the full paper. Reviewers should read the methods section carefully and look for any supplementary materials that describe experimental procedures.
### Step 3: Record Judgments With Rationales
For each domain, the reviewer records one of three judgments: low risk, high risk, or unclear risk. The judgment must be accompanied by a rationale that quotes or paraphrases the relevant text from the study. This rationale is essential for transparency and for resolving disagreements between reviewers.
### Step 4: Distinguish Risk of Bias From Reporting Quality
A common error is to rate a domain as high risk simply because the study does not report the relevant information. The SYRCLE tool distinguishes between a study that reports a biased method and a study that does not report the method at all. When the method is not described, the appropriate judgment is unclear risk, not high risk. High risk should be reserved for studies that explicitly describe a method that is known to introduce bias.
### Step 5: Incorporate the Assessment Into the Review
The risk of bias assessment should inform the synthesis of results, not sit as an appendix. Reviewers can use the assessment to perform sensitivity analyses, such as excluding studies with high risk of bias and re-running the meta-analysis to see whether the conclusions change. The assessment can also be used to grade the confidence in the evidence, with studies at high risk of bias contributing less weight to the overall conclusions.
## Recording and Reporting the Assessment
The results of the risk of bias assessment should be presented in a table that lists each included study and the judgment for each domain. The table should also include the rationales for each judgment, either in the table itself or in a supplementary file. This presentation allows readers to see the basis for the judgments and to assess whether they agree with the reviewers' decisions.
The assessment should also be described in the methods section of the systematic review. The description should state which tool was used, how many reviewers performed the assessment, how disagreements were resolved, and whether the reviewers were blinded to the study authors and institutions. This level of detail is consistent with the reporting standards promoted by the EQUATOR Network, which maintains a library of reporting guidelines for health research [1].
The review protocol should be made available before the review is conducted. The Committee on Publication Ethics Core Practices emphasize the importance of transparent research processes, including the disclosure of methods and the handling of data [2]. A pre-registered protocol that specifies the risk of bias tool and the planned analyses reduces the risk that the review methods are changed after the results are known.
## Common Failure Patterns in Risk of Bias Assessment
### Treating Unclear as Low Risk
The most common failure is to interpret an unclear rating as evidence that the study is methodologically sound. An unclear rating means that the study did not report enough information to make a judgment. It does not mean that the study is free of bias. Reviewers who default to low risk when the methods are not described will produce assessments that are too favorable.
### Confusing Risk of Bias With Study Quality
Risk of bias is one component of study quality, but the two concepts are not identical. A study can be well conducted and still have a high risk of bias in one domain. For example, a study that uses a valid animal model, measures outcomes accurately, and reports all data can still have a high risk of bias if the outcome assessor was not blinded. Reviewers should assess each domain independently instead of forming a global impression of study quality.
### Ignoring the Unit of Analysis
Reviewers who are trained in human clinical trials may overlook the unit of analysis problem in animal studies. When animals are housed in groups and the intervention is applied at the cage level, the individual animals within a cage are not independent observations. Analyses that treat each animal as independent can produce artificially precise estimates. The risk of bias assessment should flag this issue when it is present.
### Failing to Update the Assessment
Risk of bias assessments are sometimes treated as a one-time activity that is completed during the data extraction phase. In practice, the assessment may need to be updated as the review progresses. For example, if the reviewers discover that a study reported different outcomes in different sections of the paper, the selective outcome reporting domain may need to be revised.
## Limitations of the SYRCLE Tool
The SYRCLE tool is a valuable instrument, but it has limitations that reviewers should acknowledge. The tool assesses the risk of bias in the conduct and reporting of a study, but it does not assess the relevance of the animal model to the human condition. A study can be methodologically sound and still use an animal model that does not reflect the human disease being studied.
The tool also relies on the completeness and accuracy of the published report. If the authors omitted important methodological details, the reviewer cannot know whether the study was well conducted or poorly conducted. The unclear rating is a reflection of this uncertainty, but it does not resolve it.
The tool does not provide a numerical score or a summary judgment. Some reviewers prefer a quantitative approach that produces a single quality score. The SYRCLE tool deliberately avoids this approach because a single score can obscure important differences across domains. A study with a high risk of bias in one domain is not equivalent to a study with a high risk of bias in a different domain.
## Professional Escalation Criteria
When the risk of bias assessment reveals serious concerns, the review team should consider whether to escalate the issue. Escalation is appropriate when a study has a high risk of bias in multiple domains, when the authors cannot be contacted to clarify missing information, or when the findings of the review would change materially if the high-risk studies were excluded.
The review team should also consider whether the risk of bias assessment reveals a pattern across studies. If many studies in a field share the same methodological weakness, such as a lack of blinding or incomplete outcome reporting, this pattern may indicate a field-wide problem that warrants discussion in the review's limitations section.
For researchers who are conducting animal studies instead of reviewing them, the risk of bias tool can serve as a planning checklist. Designing a study that would earn low-risk ratings on all domains requires attention to randomization, allocation concealment, housing, blinding, and complete outcome reporting. The National Institutes of Health provides guidance on rigorous experimental design through its grants and funding resources, and researchers who plan to apply for NIH funding should be prepared to describe their methods for minimizing bias [3].
## Data Management and Reproducibility Context
The risk of bias assessment is one component of a broader effort to improve the reproducibility of animal research. The National Institutes of Health Data Management and Sharing Policy requires researchers to plan for the management and sharing of data generated with NIH funding [4]. This policy has implications for systematic reviewers because it may increase the availability of raw data from animal studies, which can be used to verify the results reported in published papers.
When raw data are available, reviewers can check whether the reported analyses are consistent with the data. This check can reveal discrepancies that are not apparent from the published report alone. Reviewers should consider whether to request raw data from study authors when the published report is unclear about key methodological details.
The risk of bias assessment should also be documented in a way that supports reproducibility. The assessment table, the rationales for each judgment, and the process for resolving disagreements should be recorded and made available with the review. This documentation allows other researchers to verify the assessment and to apply the same criteria to their own reviews.
## Researcher Identity and Contribution Tracking
Systematic reviews are collaborative efforts that involve multiple contributors with different roles. The Committee on Publication Ethics Core Practices emphasize that all contributors who meet the authorship criteria should be listed as authors, and that the contributions of each author should be described accurately [2]. This principle applies to systematic reviews as much as to primary research.
Researchers who conduct systematic reviews should maintain an ORCID record that documents their contributions to the review [5]. The ORCID record provides a persistent identifier that links the researcher to their work, which is useful for tracking contributions across multiple reviews and for ensuring that credit is given where it is due.
The risk of bias assessment is often performed by reviewers who are not listed as authors of the final review. These contributors should be acknowledged in the review, even if they do not meet the authorship criteria. The review should describe who performed the assessment and how their contributions were recognized.
## Frequently Asked Questions
### What is the difference between risk of bias and reporting quality?
Risk of bias refers to the likelihood that the study's results are distorted by flaws in how the study was conducted. Reporting quality refers to whether the authors described their methods and results completely and transparently. A study can be well conducted but poorly reported, which makes it difficult to assess the risk of bias. The SYRCLE tool assesses risk of bias, not reporting quality, so a study that omits methodological details receives an unclear rating instead of a high-risk rating.
### Can the SYRCLE tool be used for all types of animal studies?
The SYRCLE tool was designed for animal studies that compare two or more groups, typically in the context of preclinical intervention studies. It is most appropriate for studies that use randomization, blinding, and control groups. The tool is less suitable for descriptive studies, observational studies, or studies that do not involve a comparison between groups. Reviewers should consider whether the tool fits the design of the studies included in their review.
### How many reviewers should perform the risk of bias assessment?
The assessment should be performed by at least two reviewers working independently. This approach reduces the risk that one reviewer's subjective judgment determines the outcome. The reviewers then compare their judgments and resolve disagreements through discussion or by consulting a third reviewer. The number of reviewers and the process for resolving disagreements should be described in the review methods.
### What should I do when a study does not report the method of randomization?
When the method of randomization is not described, the appropriate judgment is unclear risk. This judgment means that the study did not provide enough information to determine whether the randomization was adequate. It does not mean that the study is biased, and it does not mean that the study is free of bias. The reviewer should record the unclear judgment and note that the method was not described.
### How do I handle studies that exclude animals from the analysis?
The reviewer should first determine whether the number of animals reported in the results matches the number that started the study. When animals are excluded, the reviewer should look for an explanation of the exclusions. Exclusions that are explained and that are unlikely to be related to the treatment earn a low-risk rating. Exclusions that are unexplained, or that appear to be related to the treatment response, earn a high-risk rating.
### Should I exclude studies with a high risk of bias from my review?
Excluding studies with a high risk of bias is one option, but it is not the only option. The reviewer can include all studies and perform a sensitivity analysis that excludes the high-risk studies to see whether the conclusions change. This approach preserves the information from all studies while testing whether the high-risk studies influence the results. The decision to exclude or include high-risk studies should be made in advance and described in the review protocol.
### How does the SYRCLE tool relate to reporting guidelines?
Reporting guidelines describe what should be included in a published paper, while risk of bias tools assess the methodological quality of the study. The two are complementary. A study that follows reporting guidelines will provide the information needed to assess risk of bias. The EQUATOR Network maintains a library of reporting guidelines that researchers can use to ensure their studies are reported completely [1].
### Where can I find the SYRCLE tool and guidance for using it?
The SYRCLE tool is described in the peer-reviewed literature and is available through the SYRCLE website. The tool is also referenced in the Research Methods Resources collection maintained by the National Library of Medicine, which provides access to authoritative biomedical research methods references [6]. Reviewers should consult the original publication of the tool for detailed guidance on applying each domain.
## Using the Evidence
| Source | Best use in this topic | Important limitation |
|---|---|---|
| [Research Methods Resources](https://www.ncbi.nlm.nih.gov/books) | official guidance | Check the linked page for current local requirements |
| [EQUATOR Network](https://www.equator-network.org/) | official guidance | Check the linked page for current local requirements |
| [Core Practices](https://publicationethics.org/core-practices) | official guidance | Check the linked page for current local requirements |
## Related Articles
- [Conducting Qualitative Interviews: A Guide for Life Science Researchers](/blog/guides/conducting-qualitative-interviews-a-guide-for-life-science-researchers)
- [The Role of the Research Ethics Committee: What Researchers Need to Know](/blog/guides/the-role-of-the-research-ethics-committee-what-researchers-need-to-know)
- [qPCR Standard Curves: How to Assess Efficiency and Quantification Limits](/blog/guides/qpcr-standard-curves-how-to-assess-efficiency-and-quantification-limits)
- [Conducting a Study: A Practical Checklist for Life Science Researchers](/blog/guides/conducting-a-study-a-practical-checklist-for-life-science-researchers)
- [Observational vs. Experimental Studies: A Decision Framework for Life Science Researchers](/blog/guides/observational-vs-experimental-studies-a-decision-framework-for-life-science-researchers)
## References and Further Reading
[1] [EQUATOR Network](https://www.equator-network.org/). EQUATOR Network.
[2] [Core Practices](https://publicationethics.org/core-practices). Committee on Publication Ethics.
[3] [NIH Grants and Funding](https://grants.nih.gov/). National Institutes of Health.
[4] [Data Management and Sharing Policy](https://sharing.nih.gov/data-management-and-sharing-policy). National Institutes of Health.
[5] [ORCID for Researchers](https://info.orcid.org/researchers). ORCID.
[6] [Research Methods Resources](https://www.ncbi.nlm.nih.gov/books). National Library of Medicine.
> This article is educational and does not replace institutional policy, professional advice, or applicable safety and regulatory requirements.